Àá½Ã¸¸ ±â´Ù·Á ÁÖ¼¼¿ä. ·ÎµùÁßÀÔ´Ï´Ù.

À¯¹æ¾Ï¿¡¼­ À¯¼¼Æ÷ºÐ¼®ÀÇ ÀÇÀÇ The Significance of DNA Flow-cytometry in Breast Cancer

´ëÇѾÏÇÐȸÁö 1997³â 29±Ç 5È£ p.738 ~ 747
¹éÀΰæ, Á¤¿ìÈñ, ÀÌÈñ´ë,
¼Ò¼Ó »ó¼¼Á¤º¸
¹éÀΰæ (  ) 
¿¬¼¼´ëÇб³ ÀÇ°ú´ëÇÐ ¿Ü°úÇб³½Ç

Á¤¿ìÈñ (  ) 
¿¬¼¼´ëÇб³ ÀÇ°ú´ëÇÐ º´¸®Çб³½Ç
ÀÌÈñ´ë (  ) 
¿¬¼¼´ëÇб³ ÀÇ°ú´ëÇÐ ¿Ü°úÇб³½Ç

Abstract

°á·Ð
À¯¹æ¾Ï¿¡¼­ DNA flowcytometry ºÐ¼®»ó diploidy (34.5%)º¸´Ù´Â aneuploidy(65.5%)°¡ ¸¹
¾ÒÀ¸¸ç S-phase fractionÀÇ Áß¾Ó°ªÀº 11.2%À̾ú°í aneuploidyÀÇ °æ¿ì diploidy¿¡ ºñÇÏ¿© ³ô
Àº SPF ¼öÄ¡¸¦ º¸¿´´Ù(p<0.05). ¶ÇÇÑ ¸²ÇÁÀý ÀüÀÌ°¡ ÀÖ´Â À¯¹æ¾ÏÀÇ °æ¿ì ÀüÀÌ°¡ ¾ø´Â °æ¿ì
¿¡ ºñÇÏ¿© ³ôÀº ¼öÄ¡ÀÇ SPF¼öÄ¡¸¦ º¸¿©(p<0.05) DNA ÇÔ·®ÀÇ º¯È­°¡ ±âÁ¸ÀÇ ¿¹ÈÄÀÎÀÚµé°ú
¿¬°ü¼ºÀ» °¡Áö¸é¼­ ÃøÁ¤°¡´ÉÇÑ ¿¹ÈÄÀÎÀڷμ­ °¡´É¼ºÀÌ ÀÖÀ½À» ¾Ë ¼ö ÀÖ¾ú´Ù. ¿¹ÈÄÀû °¡Ä¡¸¦
À§ÇÑ ¿¬±¸¿¡¼­ DNA ploidy³ª S-phase fraction¿¡ µû¸¥ »ýÁ¸À² ¹× ¹«º´»ýÁ¸À²Àº aneuploidy
À̰ųª high SPFÀÇ °æ¿ì°¡ diploidy³ª low SPF¿¡ ºñÇÏ¿© Åë°èÀû À¯ÀǼºÀº ¾ø¾úÁö¸¸ ³ôÀº
¼öÄ¡¸¦ º¸¿© Á»´õ Àå±â°£ÀÇ ÃßÀûÁ¶»ç¸¦ ÅëÇÏ¿© ¿¹ÈÄÀÎÀÚ ¹× ¿¹ÃøÀÎÀڷμ­ÀÇ ¿ªÇÒÀ» ¾Ë ¼ö
ÀÖÀ» °ÍÀ¸·Î ±â´ëµÈ´Ù.
#ÃÊ·Ï#
Purpose : To evaluate the relationship between nuclear DNA contents and prognostic
factors and survival in breast cancer patients.
Materials and Methods : We determined nuclear DNA content from 91
paraffin-embedded malignant breast tumors and evaluated relationship between DNA
nuclear content and well-known prognostic indicators of breast cancer and the survival
of the patients by statistical analyses.
Results : Twenty nine(34.5%) of the 91 tumors examined were diploid, and the
remainder(65.5%) contained one or more aneuploid clones. 5-phase fraction(SPF) ranged
from 1.4 to 68.3%(median 11.2%) and it was higher in aneuploidy tumors than in diploid
tumors(p<0.05). Positive axillary lymph nodes were found in 72.7% of the patients who
had a tumor with a high SPF (above the median 11.2%) and in 27.3% of those with
tumor with low SPF (below median)(p<0.05). The overall survival rate was 96.1% in
DNA diploid and 87.6% in DNA aneuploid tumors, showing that DNA ploidy had no
prognostic significance in breast cancers. The actuarial survival rates were 96.4% and
86.3% for low and high SPF, respectively(p=0.28). The patients with high SPF showed
high disease free survival rate compared to the patients with low SPF but the difference
had no statistical significance.
Conclusion : Our results indicate DNA aneuploid tumors were more prevalent in
breast cancer patients with high SPF or lymph node metastasis and larger patient
accumulation with longer follow-up period will be helpful to identify the relationship
between flow-cytometrical analysis and prognosis.

Å°¿öµå

DNA flow-cytometry; S-phase fraction; DNA index; Breast cancer;

¿ø¹® ¹× ¸µÅ©¾Æ¿ô Á¤º¸

 

µîÀçÀú³Î Á¤º¸

KoreaMed
KAMS